eCollection 2017.
HSD11B1 rs846908 Polymorphisms and Tacrolimus Concentrations: Quantum Chemical Analysis and Implication in Patients With Renal Transplantation
Affiliations
- PMID: 28197525
- PMCID: PMC5295653
Item in Clipboard
HSD11B1 rs846908 Polymorphisms and Tacrolimus Concentrations: Quantum Chemical Analysis and Implication in Patients With Renal Transplantation
J Nephropharmacol.
.
Free PMC article
Abstract
No abstract availableKeywords: Kidney; Polymorphism; Tacrolimus; Transplantation.
Similar articles
-
Associations of HSD11B1 polymorphisms with tacrolimus concentrations in Chinese renal transplant recipients with prednisone combined therapy.Drug Metab Dispos. 2015 Apr;43(4):455-8. doi: 10.1124/dmd.114.062117. Epub 2015 Jan 13. Drug Metab Dispos. 2015. PMID: 25587129 Clinical Trial.
-
Influence of ABCB1 polymorphisms and haplotypes on tacrolimus nephrotoxicity and dosage requirements in children with liver transplant.Br J Clin Pharmacol. 2009 Sep;68(3):413-21. doi: 10.1111/j.1365-2125.2009.03461.x. Br J Clin Pharmacol. 2009. PMID: 19740399 Free PMC article.
-
Impact of cytochrome P450 3A and ATP-binding cassette subfamily B member 1 polymorphisms on tacrolimus dose-adjusted trough concentrations among Korean renal transplant recipients.Transplant Proc. 2012 Jan;44(1):109-14. doi: 10.1016/j.transproceed.2011.11.004. Transplant Proc. 2012. PMID: 22310591
-
The influence of genetic polymorphisms of cytochrome P450 3A5 and ABCB1 on starting dose- and weight-standardized tacrolimus trough concentrations after kidney transplantation in relation to renal function.Clin Chem Lab Med. 2006;44(10):1192-8. doi: 10.1515/CCLM.2006.229. Clin Chem Lab Med. 2006. PMID: 17032130
-
Donor ABCB1 3435 C>T genetic polymorphisms influence early renal function in kidney transplant recipients treated with tacrolimus.Pharmacogenomics. 2016 Feb;17(3):249-57. doi: 10.2217/pgs.15.165. Epub 2016 Jan 19. Pharmacogenomics. 2016. PMID: 26784512
Cited by 5 articles
-
Angiotensin-converting enzyme G2350A gene polymorphisms and hypertension among patients with intracerebral hemorrhage.J Taibah Univ Med Sci. 2019 Oct 11;14(5):479-480. doi: 10.1016/j.jtumed.2019.09.002. eCollection 2019 Oct. J Taibah Univ Med Sci. 2019. PMID: 31728149 Free PMC article. No abstract available.
-
Association of FTO rs9939609 with Obesity.Med Princ Pract. 2018;27(5):496. doi: 10.1159/000490495. Epub 2018 May 30. Med Princ Pract. 2018. PMID: 29847830 Free PMC article. No abstract available.
-
Methylenetetrahydrofo late reductase C677T polymorphism and schizophrenia: Effect of molecular change.J Res Med Sci. 2018 Mar 27;23:20. doi: 10.4103/jrms.JRMS_915_17. eCollection 2018. J Res Med Sci. 2018. PMID: 29692817 Free PMC article. No abstract available.
-
Aggressive Behavior and Short-Long Polymorphisms of Monoamine Oxidase A: An Example of Effect of Genetic Molecular Mass Change in Psychological Medicine.Indian J Psychol Med. 2017 Nov-Dec;39(6):833-834. doi: 10.4103/IJPSYM.IJPSYM_247_17. Indian J Psychol Med. 2017. PMID: 29284828 Free PMC article. No abstract available.
-
WWOX rs11644322 Polymorphism, Gemcitabine, and Pancreatic Cancer.Indian J Med Paediatr Oncol. 2017 Jul-Sep;38(3):409-410. doi: 10.4103/ijmpo.ijmpo_125_17. Indian J Med Paediatr Oncol. 2017. PMID: 29200707 Free PMC article. No abstract available.
References
-
- Wong CJ, Pagalilauan G. Primary Care of the Solid Organ Transplant Recipient. Med Clin North Am. 2015;99:1075–103. - PubMed
-
- Garnock-Jones KP. Tacrolimus prolonged release (Envarsus®): a review of its use in kidney and liver transplant recipients. Drugs. 2015;75:309–20. - PubMed
-
- Hronová K, Šíma M, Světlík S, Matoušková O, Slanař O. Pharmacogenetics and immunosuppressive drugs. Expert Rev Clin Pharmacol. 2014;7:821–35. - PubMed
-
- Liu X, Li J, Fu Q, Liu S, Zhang Y, Wang X. et al. Associations of HSD11B1 polymorphisms with tacrolimus concentrations in Chinese renal transplant recipients with prednisone combined therapy. Drug Metab Dispos. 2015;43:455–8. - PubMed
-
- Wiwanitkit V. Analysis of binding energy activity of imatinib and Abl tyrosine kinase domain based on simple consideration for conformational change: an explanation for variation in imatinib effect in mutated type. Indian J Cancer. 2009;46:335–6. - PubMed
LinkOut - more resources
Full Text Sources